Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Patients With Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Discovery
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
Cancer Discov 2023 Jan 26;[EPub Ahead of Print], P Dharanipragada, X Zhang, S Liu, SH Lomeli, A Hong, Y Wang, Z Yang, KZ Lo, A Vega-Crespo, A Ribas, SJ Moschos, G Moriceau, RS LoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.